# Combined THC and CBD for OUD and Chronic Pain

> **NCT06544291** · PHASE2 · RECRUITING · sponsor: **Yale University** · enrollment: 147 (estimated)

## Conditions studied

- Chronic Pain
- Opioid Use Disorder

## Interventions

- **DRUG:** CBD 300mg
- **DRUG:** CBD 600mg
- **DRUG:** Placebo 0mg

## Key facts

- **NCT ID:** NCT06544291
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2028-01-28
- **Final completion:** 2028-01-28
- **Target enrollment:** 147 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544291, "Combined THC and CBD for OUD and Chronic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06544291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*